| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales | $1.19B+23.9% | $963.0M-5.0% | $1.01B+8.3% | $936.2M+3.3% | $906.6M+39.5% | $649.6M-19.7% | $809.2M-99.9% | $876.28B+4.4% | $839.42B |
| Cost of products sold | $834.0M+30.9% | $637.3M-0.2% | $638.7M+7.5% | $594.1M+0.6% | $590.8M+37.6% | $429.4M-18.4% | $526.0M-99.9% | $571.28B+3.1% | $554.36B |
| Gross profit | $359.4M+10.4% | $325.7M-13.1% | $374.8M+9.6% | $342.1M+8.4% | $315.7M+43.4% | $220.2M-22.2% | $283.2M-99.9% | $305.00B+7.0% | $285.06B |
| Selling expenses | $133.6M+21.4% | $110.0M+4.5% | $105.3M+2.7% | $102.5M+3.4% | $99.2M+29.0% | $76.9M-15.5% | $91.1M-99.9% | $97.92B-4.0% | $101.96B |
| General and administrative expenses | $178.3M+66.3% | $107.2M+0.5% | $106.8M+12.6% | $94.8M-7.2% | $102.1M+34.3% | $76.0M-2.4% | $77.9M-99.9% | $83.57B-2.4% | $85.61B |
| Research and development expenses | $21.4M-10.3% | $23.9M-8.9% | $26.2M+25.1% | $20.9M+36.4% | $15.4M+23.7% | $12.4M+9.7% | $11.3M-99.9% | $13.49B-0.9% | $13.62B |
| Net gain on sales of businesses | -$103.3M | $0 | $0 | — | — | — | $176K-100.0% | $25.67B | $0 |
| Loss on impairment of goodwill | $200.0M | $0 | $0 | — | — | — | — | — | — |
| Amortization of intangibles | $48.8M+62.8% | $29.9M+1.9% | $29.4M+13.1% | $26.0M+2.8% | $25.3M+100.3% | $12.6M-2.5% | $12.9M-99.9% | $14.90B-4.2% | $15.55B |
| Income from operations | -$119.3M-318.7% | $54.6M-49.1% | $107.1M+9.5% | $97.8M+32.6% | $73.8M+74.6% | $42.3M-53.0% | $89.8M-99.9% | $69.44B+1.6% | $68.33B |
| Interest and debt expense | $61.1M+88.6% | $32.4M-14.6% | $38.0M+35.8% | $27.9M+38.8% | $20.1M+66.6% | $12.1M-15.1% | $14.2M-99.9% | $17.14B-13.1% | $19.73B |
| Cost of debt refinancing | $24.2M | $0 | $0 | — | $14.8M | $0 | — | — | — |
| Investment (income) loss, net | -$2.2M-67.6% | -$1.3M+26.0% | -$1.8M-458.4% | -$315K-584.8% | -$46K+97.3% | -$1.7M-90.0% | -$891K+99.9% | -$727.0M-363.1% | -$157.0M |
| Foreign currency exchange loss (gain), net | $5.6M+74.6% | $3.2M+74.1% | $1.8M+183.4% | -$2.2M-239.1% | $1.6M+67.3% | $941K+162.2% | -$1.5M-100.2% | $843.0M-45.2% | $1.54B |
| Other (income) expense, net | -$1.5M-105.9% | $25.8M+239.3% | $7.6M+466.7% | -$2.1M-84.7% | -$1.1M-105.4% | $20.9M+2385.1% | $839K+100.1% | -$716.0M+71.0% | -$2.47B |
| Income (Loss) before income tax expense | -$206.5M-3651.3% | -$5.5M-108.9% | $61.5M-17.4% | $74.5M+93.7% | $38.4M+281.6% | $10.1M | — | — | — |
| Income tax (benefit) expense | $22.9M+6348.0% | -$367K-102.5% | $14.9M-42.8% | $26.0M+196.4% | $8.8M+805.8% | $970K-94.5% | $17.5M-99.8% | $10.32B-62.6% | $27.62B |
| Net income (loss) | -$229.4M-4365.5% | -$5.1M-111.0% | $46.6M-3.7% | $48.4M | — | $9.1M-84.7% | $59.7M-99.9% | $42.58B+93.0% | $22.07B |
| Net loss attributable to noncontrolling interest | $98K | $0 | $0 | — | — | — | — | — | — |
| Net income (loss) attributable to the Company | -$229.5M-4367.4% | -$5.1M-111.0% | $46.6M-3.7% | $48.4M+63.3% | $29.7M | — | — | — | — |
| Average basic shares outstanding (in shares) | 28.7M-0.1% | 28.7M+0.0% | 28.7M+0.4% | 28.6M+2.0% | 28.0M+17.3% | 23.9M+1.2% | 23.6M+1.5% | 23.3M+1.9% | 22.8M |
| Average diluted shares outstanding (in shares) | 28.7M-0.1% | 28.7M-1.0% | 29.0M+0.7% | 28.8M+1.5% | 28.4M+17.5% | 24.2M+1.3% | 23.9M+0.8% | 23.7M+1.4% | 23.3M |
| Basic income (loss) per common share (in dollars per share) | -$7.40-4011.1% | -$0.18-111.1% | $1.62-4.1% | $1.69+59.4% | $1.06+178.9% | $0.38-85.0% | $2.53+38.3% | $1.83+88.7% | $0.97 |
| Diluted income (loss) per common share (in dollars per share) | -$7.40-4011.1% | -$0.18-111.2% | $1.61-4.2% | $1.68+61.5% | $1.04+173.7% | $0.38-84.8% | $2.50+38.9% | $1.80+89.5% | $0.95 |
| Dividends declared per common share (in dollars per share) | $0.28+0.0% | $0.28+0.0% | $0.28+0.0% | $0.28+12.0% | $0.25+4.2% | $0.24+0.0% | $0.24+14.3% | $0.21+23.5% | $0.17 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.